In our attempt to investigate its biological functions using CRISPR‐Cas9 technology to delete RPAP2 in HCC cells, we failed to generate RPAP2‐deleted cells, indicating the essential role of RPAP2 in HCC cell growth. This evidence concerns the gene RPAP2 and hepatocellular carcinoma.